Announced today, the AC & the Structural Genomics Consortium have partnered to tackle an ongoing challenge in biomedicine: developing bioactive molecules with drug-like properties, becoming "a force multiplier for 🇨🇦-led innovation in pharmaceutical sciences." acceleration.utoronto.ca/news/global-...
